Management Change5 Oct 2026, 05:00 pm
Sudeep Pharma MD Ceases to be Senior Management Personnel
AI Summary
Sudeep Pharma Ltd announced changes in its Senior Management Personnel (SMP) due to the completion of contractual arrangements with Mr. Sendhil Pani. Mr. Pani, who was the Managing Director of Sudeep Pharma USA Inc. (a wholly-owned subsidiary), will no longer be associated with the company as SMP. This cessation is effective from October 2nd, 2026, as per SEBI Listing Regulations. The company has provided details as required by Regulation 30 and Schedule III of the SEBI Listing Regulations.
Key Highlights
- Mr. Sendhil Pani ceases to be Senior Management Personnel.
- Cessation is due to completion of contractual arrangements.
- Effective date of cessation is October 2nd, 2026.
- Disclosure made as per SEBI Listing Regulations.
Price Impact
More from SUDEEPPHRM